Shenzhen Yifeng Investment Management Enterprise
Shenzhenefungcapital.com
Overview
Shenzhen Yifeng Investment Management Enterprise, also known as Efung Capital, is a venture capital and private equity firm founded in 2007. The firm is based in Shenzhen, China, and specializes in investments within the healthcare, life sciences, biopharmaceuticals, and high-end medical device sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Westlake Therapeutics | Jun 2026 | Series B | Co-investor |
| Shanghai Carbonology Technology Co., Ltd. | Jun 2026 | Series A | Co-investor |
| Laviana Pharma | Dec 2022 | Series C Extension | Lead |
| Westlake Therapeutics | Jun 2022 | Series A Extension | Lead |
| Guangzhou Yinming Biomedical Technology | Sep 2021 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
